Short communicationThe fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells
Introduction
Mitochondria, the cells’ powerhouse of energy, are also an important checkpoint in the signaling pathways of cell death. In response to a wide range of lethal stimuli, mitochondria undergo changes in their membrane permeability (MMP) that triggers the cytosolic translocation of pro-apoptotic proteins such as cytochrome c (Cyt c), apoptosis inducing factor (AIF), endonuclease G (EndoG) and Smac/Diablo that normally reside in the inter-membranous space (for reviews: Green and Kroemer, 2004, Kroemer et al., 2007). Thus, MMP activates cytosolic and nuclear caspase-dependent and caspase-independent signaling cascades that coordinate the final steps of apoptosis. It is now well established that MMP could be induced by diverse stimuli and involve either outer membrane permeabilization (OMP) or inner membrane permeabilization (IMP); both processes are under the control of Bcl-2 family proteins. IMP is often related to the so-called “permeability transition”, a process involving prolonged opening of the mitochondrial polyprotein complex, the permeability transition pore complex (PTPC), and manifests as the early loss of integrity of the IM permeability barrier associated with a loss of the transmembrane potential (ΔΨm) and arrest of mitochondrial bioenergetic functions. Despite intense research and presumably due to tissue specificity, the PTPC composition is still a matter of debate. In a variety of human cancers, such as cervical carcinoma, breast cancer, lung and liver carcinomas, the components of the PTPC might involve the outer membrane voltage-dependent anion channel (VDAC), the inner membrane ANT, and the matrix protein cyclophilin D (CypD) (Grimm and Brenner, 2006, Faustin et al., in press), notwithstanding the association of other mitochondrial proteins, such as the phosphate carrier (Leung et al., 2008).
The ANTs form a sub-family of mitochondrial ADP/ATP transporters (Pfaff and Klingenberg, 1968). The human genome contains at least four genes encoding four protein isoforms, namely ANT1–4. The four isoforms are highly homologous (68–88%), expressed in a tissue-, hormone-, and development-specific manner and conserved through evolution, although ANT3 is not present in mice (Dorner et al., 1997, Stepien et al., 1992). Wan-1, the C. elegans ortholog of mammalian ANT is an important cell death regulator, which cooperates with the core cell death machinery (Shen et al., 2009). In human, rat, mouse, and partially in yeast, pro-apoptotic stimuli (e.g. calcium, ROS, and carboxyatractyloside) favoring a non-specific lethal pore conformation of ANT1 and 3 (at least in human) lead to the classical hallmarks of mitochondrial apoptosis (Beutner et al., 1996, Bauer et al., 1999, Marzo et al., 1998a, Marzo et al., 1998b, Zamarin et al., 2005, Zamora et al., 2004). The pro-apoptotic ANT isoforms cooperate with a panel of proteins, in particular members of the Bcl-2 family (e.g. Bax, Bid, Bcl-2) to form a new class of lethal channels. These dynamic interactions are notable during apoptotic signaling in response to chemotherapeutic drugs, ischemia/reperfusion, and viral infection (Belzacq et al., 2001, Cao et al., 2001, Zamarin et al., 2005, Zamora et al., 2004, Jacotot et al., 2001). In contrast, the ANT2 isoform, which is overexpressed in proliferating cells and some human cancers, has been reported to play an anti-apoptotic role (Stepien et al., 1992). As a consequence, ANT2 inactivation by RNA interference favors chemotherapy-induced cell death in vitro and in vivo (Le Bras et al., 2006, Jang et al., 2008). Whether ANT isoforms could have a direct effect on cell proliferation has not yet been established. Interestingly, the double knock-out of ANT1 and 2 in mouse liver did not have any major effect on the calcium-induced permeability transition in liver mitochondria (i.e. permeability transition requires more calcium), but abolished the sensitivity of ANT ligands, suggesting that, at least in mice, ANT1 and 2 are dispensable for permeability transition (Kokoszka et al., 2004). However, this scenario might not be entirely true based on two possibilities: (1) compensatory phenomenon in conventional knock-out mice cannot be excluded, and (2) the existence of previously unknown ANT isoforms, like the recently discovered ANT4 (Dolce et al., 2005). As a corollary, ADP/ATP carriers were shown to be required for efficient MMP induction, Cyt c release and apoptosis in yeast, independent of the translocase activity (Pereira et al., 2007).
Whereas the ADP/ATP antiport activity of ANT4 has been extensively characterized (Dolce et al., 2005), not much is known regarding its involvement in PTPC and mitochondria-dependent apoptosis. ANT4 is highly conserved through evolution, and notably, human ANT4 mRNA is present in liver, brain and testis. In mice, although ANT4 is expressed in pluripotent stem cells and germ cells, its physiological expression is restricted to developing gametes in adults (Rodic et al., 2005). Ant4-deficient mice are infertile thus strongly suggesting that ANT4 could serve as the sole ADP/ATP translocase isoform during spermatogenesis, precisely where the sex chromosome-linked Ant2 gene is inactivated. In addition, Ant4-deficient male mice exhibit enhanced levels of apoptosis within the testis suggesting an anti-apoptotic role of this isoform (Brower et al., 2009).
To determine the role of human ANT4 in apoptosis, we investigated the effect of its stable overexpression in tumoral cell lines in comparison with the pro-apoptotic ANT3 isoform. Here we report that ANT4-overexpressing cells exhibited increased growth rate without a significant change in cell morphology or mitochondrial respiration. Similarly to ANT3, ANT4 overexpression resulted in a decrease in intracellular hydrogen peroxide (H2O2) without affecting the levels of superoxide anion (O2−). Of note, in contrast to the apoptosis sensitizing activity of ANT3, ANT4 expression had an inhibitory effect on apoptosis. Altogether, these data suggest a new cytoprotective function of the human ANT4 isoform.
Section snippets
Materials and methods
All chemicals were purchased from Sigma–Aldrich unless otherwise indicated.
Contrasting effects of ANT3 and 4 overexpression on cell proliferation, cell morphology and mitochondrial topology
To investigate the role of human ANT4 in mitochondrial apoptosis, we first generated cell lines expressing various isoforms of ANT. HeLa cells were used as a model system as these cells constitutively express ANT1, 2, and 3, but not the ANT4 isoform (data not shown). We generated the following HeLa cell variants: (a) cells overexpressing ANT4 (Q9H0C2, 315aa) and (b) cells overexpressing ANT3 isoform (P12236, 298aa; positive control for pro-apoptotic isoform). The integration of the ant gene
Acknowledgments
CB is supported by grants funded by Association pour la Recherche sur le Cancer (ARC), Egide, l’Agence Nationale pour la Recherche (ANR, ANR-08PCVI-0008-01) and l’Institut National pour le Cancer (INCa, 2008-1-PL BIO-04-CNRS ON1). CD, CM, and EM received fellowships from the Ministère de l’Enseignement et de la Recherche (MENR) and OS received a postdoctoral fellowship from the DIM Sent, Région Ile de France. E. Maillier is acknowledged for his technical help.
References (38)
- et al.
Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore
FEBS Lett
(1996) - et al.
Evolutionarily conserved mammalian adenine nucleotide translocase 4 is essential for spermatogenesis
J Biol Chem
(2007) - et al.
Mitochondrial ATP synthasome: three-dimensional structure by electron microscopy of the ATP synthase in complex formation with carriers for Pi and ADP/ATP
J Biol Chem
(2004) - et al.
A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution
FEBS Lett
(2005) - et al.
The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition
J Biol Chem
(2008) - et al.
Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation
J Biol Chem
(1992) - et al.
Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells
FEBS Lett
(2004) - et al.
Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis
J Cell Biol
(1999) - et al.
The adenine nucleotide translocator: a new potential chemotherapeutic target
Curr Drug Targets
(2003) - et al.
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437
Oncogene
(2001)
Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator
Oncogene
Adenine nucleotide translocase 4 deficiency leads to early meiotic arrest of murine male germ cells
Reproduction
Intracellular Bax translocation after transient cerebral ischemia: implications for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death
J Cereb Blood Flow Metab
Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells
Cell Death Differ
Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis
Oncogene
Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function
Mol Cell Biochem
The pathophysiology of mitochondrial cell death
Science
The permeability transition pore in cancer cell death
Oncogene
Cited by (30)
Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid–polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model
2020, European Journal of Pharmaceutics and BiopharmaceuticsThe yeast mitochondrial permeability transition is regulated by reactive oxygen species, endogenous Ca<sup>2+</sup> and Cpr3, mediating cell death
2018, Biochimica et Biophysica Acta - BioenergeticsCitation Excerpt :For example, ANT1/2-null mitochondria could be induced to undergo swelling and require more Ca2+ to activate the pore [21]. The interpretation of these results is complicated since all rodents have an additional isoform, ANT4 [31]. In light of these confusing situations, two hypothetical models are intriguing: in one model, the pore is formed on the chaperone CypD by non-specific mitochondrial carrier proteins when they are aggregated or denatured [32]; in the other, the pore forms at the interface between interacting domains of the mitochondrial phosphate carrier, ANT and ATP synthase following calcium-triggered conformational changes facilitated by CypD [33].
Expression and putative role of mitochondrial transport proteins in cancer
2017, Biochimica et Biophysica Acta - BioenergeticsCitation Excerpt :Its role in cancer has not been studied in much detail, but it was shown to cause anti-apoptotic effects in cultured cancer cells, similarly to AAC2. Overexpression of AAC2 also reduced cancer cell sensitivity to chemotherapeutics ionidamine and staurosporine [78]. To conclude, the four AAC isoforms, despite high similarity, have opposing effects on apoptosis and cell survival (Fig. 3).
Mitochondrion: A Common Organelle for Distinct Cell Deaths?
2017, International Review of Cell and Molecular BiologySolute carriers (SLCs) in cancer
2013, Molecular Aspects of MedicineIncreased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents
2012, Biochemical PharmacologyCitation Excerpt :In human, four isoforms of ANT (ANT1–4) and three isoforms of VDAC (VDAC1–3) have been identified and demonstrated to exert opposite effects on apoptosis. Indeed, some isoforms (VDAC1, ANT1, ANT3) act predominantly as pro-apoptotic proteins [9–11], whereas others (VDAC2, ANT2, ANT4) protect from cell death [12–14]. Although VDAC proteins are highly conserved across species, the specific function of individual VDAC isoforms is poorly understood and remains to be elucidated.
- 1
Contributed equally to the work.
- 2
Present address: INSERM U769, Université Paris-Sud 11, Faculté de Pharmacie, 5, Rue J.-B. Clément, Châtenay-Malabry cedex, France.
- 3
Present address: Mitologics S.A.S. Hôpital Robert Debré, 48, Boulevard Sérurier, 75019 Paris, France.
- 4
Present address: Imperial College London, Department of Reproductive Biology, Cancer division, Hammersmith Hospital, DuCane Rd., London, W120NN, United Kingdom.